Mostrando 1,221 - 1,239 Resultados de 1,239 Para Buscar '"Central Africa"', tiempo de consulta: 0.31s Limitar resultados
  1. 1221
  2. 1222
    por Boadu, Isaac
    Publicado 2022
    “…This ranged from 3.5% in the Central Africa Republic to 49.7% in Namibia. The most common type of MC used were injections (39.4%), condoms (17.5%) and implants (26.5%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 1223
    “…Regarding sub-regional distribution, comprehensive knowledge of HIV/AIDS in Southern Africa was 73.2%, followed by East Africa (52.4%), West Africa (43.6%), and Central Africa (35.5%). The study showed higher odds of comprehensive knowledge of HIV/AIDS among married women who had decision making power (yes-aOR = 1.20, 95% CI; 1.16–1.25) compared to those who had no decision-making power. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 1224
  5. 1225
    “…BACKGROUND: The Kin-Antwerp project aimed at improving the quality of care provided to patients with diabetes in Kinshasa, the Democratic Republic of the Congo in Central Africa, including the digitalisation of routine clinical data to improve patients’ follow-up. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 1226
    “…Across the SSA regions, the highest prevalence of CSO was reported in Southern Africa (2.64%, 95% CI: 2.17, 3.17) followed by the Central Africa region (2.21%, 95% CI: 2.06, 2.37). Under five children aged 12–23 months (AOR = 0.45, 95% CI: 0.34, 0.59), 24–35 months (AOR = 0.41, 95% CI: 0.32, 0.52), 36–59 months (AOR = 055, 95% CI: 0.43, 0.70), ever had no vaccination (AOR = 1.25, 95% CI: 1.09, 1.54), under-five children born from 25 to 34 years mother (AOR = 0.75, 95% CI: 0.61, 0.91), under-five children born from overweight/obese mothers (AOR = 1.63, 95% CI: 1.14, 2.34), and under-five children living in West Africa (AOR = 0.77, 95% CI: 0.61, 0.96) were significant determinants for under-five CSO. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 1227
    “…In immigrant- and refugee-only models stratified by generation, region of origin was associated with uptake, compared with the overall rate, with the lowest odds observed in immigrants and refugees from Eastern Europe (children: aOR, 0.40; 95% CI, 0.35-0.46; adolescents: aOR, 0.41; 95% CI, 0.38-0.43) and Central Africa (children: aOR, 0.24; 95% CI, 0.16-0.35; adolescents: aOR, 0.51,CI: 0.45-0.59) and the highest odds observed in immigrants and refugees from Southeast Asia (children: aOR, 2.68; 95% CI, 2.47-2.92; adolescents aOR, 4.42; 95% CI, 4.10-4.77). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 1228
    “…Nigeria (35), Tunisia (25) and South Africa (23) contributed the majority of cases for data collection with a clear paucity of reportable information available from Central Africa. Of the 149 cases from the African continent, the majority were from patients aged ten years and younger with a decrease in reported cases in patients with increasing age. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 1229
    “…It is cultivated mostly by poor farmers in developing countries, with 80% of production taking place in the dry savannah of tropical West and Central Africa. Cowpea is largely an underexploited crop with relatively little genomic information available for use in applied plant breeding. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  10. 1230
  11. 1231
    Publicado 2016
    “…Regional mean BMIs in 2014 for men ranged from 21·4 kg/m(2) in central Africa and south Asia to 29·2 kg/m(2) (28·6–29·8) in Polynesia and Micronesia; for women the range was from 21·8 kg/m(2) (21·4–22·3) in south Asia to 32·2 kg/m(2) (31·5–32·8) in Polynesia and Micronesia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 1232
  13. 1233
  14. 1234
    “…So far, limited data have been reported from Africa including in Central Africa. The objective of this study was to provide data on anti-S1 spike total IgG and neutralizing antibodies in vaccinated and non-vaccinated including naturally infected Congolese population during B.1.214.1 and B.1.617.2 variant waves. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 1235
    “…METHODS AND FINDINGS: HIV-exposed infants were eligible for this retrospective cohort analysis if enrolled at <18 months at 198 clinics in 10 countries across 5 IeDEA regions: East Africa (EA), Central Africa (CA), West Africa (WA), Southern Africa (SA), and the Caribbean, Central, and South America network (CCASAnet). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 1236
    “…While, women who accessed contraceptives from private clinics (AOR = 0.64, 95%CI: 0.61, 0.67), pharmacies (AOR = 0.37, 95%CI: 0.35, 0.40), and others (AOR = 0.47, 95%CI: 0.43, 0.52), women in East Africa (AOR = 0.70, 95% CI: 0.67, 0.73), Central Africa (AOR = 0.52, 95% CI: 0.47, 0.57), and South Africa (AOR = 0.36, 95% CI: 0.32, 0.40) were associated with decreased odds of informed choice of contraceptive methods. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 1237
    “…On the other hand, distance to a health facility (APR = 0.87, 95% CI: 0.84, 0.91), and being in central Africa (APR = 0.87, 95% CI: 0.84, 0.91) were significantly associated with a lower prevalence of mother's healthcare-seeking behavior for symptoms of acute respiratory infection in under-five children. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 1238
    “…Artesunate-pyronaridine versus artemether-lumefantrine In two multicentre trials, enrolling mainly older children and adults from west and south-central Africa, both artesunate-pyronaridine and artemether-lumefantrine had fewer than 5% PCR adjusted treatment failures during 42 days of follow-up, with no differences between groups (two trials, 1472 participants, low quality evidence). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 1239
    por Cromwell, Elizabeth A., Osborne, Joshua C. P., Unnasch, Thomas R., Basáñez, Maria-Gloria, Gass, Katherine M., Barbre, Kira A., Hill, Elex, Johnson, Kimberly B., Donkers, Katie M., Shirude, Shreya, Schmidt, Chris A., Adekanmbi, Victor, Adetokunboh, Olatunji O., Afarideh, Mohsen, Ahmadpour, Ehsan, Ahmed, Muktar Beshir, Akalu, Temesgen Yihunie, Al-Aly, Ziyad, Alanezi, Fahad Mashhour, Alanzi, Turki M., Alipour, Vahid, Andrei, Catalina Liliana, Ansari, Fereshteh, Ansha, Mustafa Geleto, Anvari, Davood, Appiah, Seth Christopher Yaw, Arabloo, Jalal, Arnold, Benjamin F., Ausloos, Marcel, Ayanore, Martin Amogre, Baig, Atif Amin, Banach, Maciej, Barac, Aleksandra, Bärnighausen, Till Winfried, Bayati, Mohsen, Bhattacharyya, Krittika, Bhutta, Zulfiqar A., Bibi, Sadia, Bijani, Ali, Bohlouli, Somayeh, Bohluli, Mahdi, Brady, Oliver J., Bragazzi, Nicola Luigi, Butt, Zahid A., Carvalho, Felix, Chatterjee, Souranshu, Chattu, Vijay Kumar, Chattu, Soosanna Kumary, Cormier, Natalie Maria, Dahlawi, Saad M. A., Damiani, Giovanni, Daoud, Farah, Darwesh, Aso Mohammad, Daryani, Ahmad, Deribe, Kebede, Dharmaratne, Samath Dhamminda, Diaz, Daniel, Do, Hoa Thi, El Sayed Zaki, Maysaa, El Tantawi, Maha, Elemineh, Demelash Abewa, Faraj, Anwar, Fasihi Harandi, Majid, Fatahi, Yousef, Feigin, Valery L., Fernandes, Eduarda, Foigt, Nataliya A., Foroutan, Masoud, Franklin, Richard Charles, Gubari, Mohammed Ibrahim Mohialdeen, Guido, Davide, Guo, Yuming, Haj-Mirzaian, Arvin, Hamagharib Abdullah, Kanaan, Hamidi, Samer, Herteliu, Claudiu, de Hidru, Hagos Degefa, Higazi, Tarig B., Hossain, Naznin, Hosseinzadeh, Mehdi, Househ, Mowafa, Ilesanmi, Olayinka Stephen, Ilic, Milena D., Ilic, Irena M., Iqbal, Usman, Irvani, Seyed Sina Naghibi, Jha, Ravi Prakash, Joukar, Farahnaz, Jozwiak, Jacek Jerzy, Kabir, Zubair, Kalankesh, Leila R., Kalhor, Rohollah, Karami Matin, Behzad, Karimi, Salah Eddin, Kasaeian, Amir, Kavetskyy, Taras, Kayode, Gbenga A., Kazemi Karyani, Ali, Kelbore, Abraham Getachew, Keramati, Maryam, Khalilov, Rovshan, Khan, Ejaz Ahmad, Khan, Md Nuruzzaman Nuruzzaman, Khatab, Khaled, Khater, Mona M., Kianipour, Neda, Kibret, Kelemu Tilahun, Kim, Yun Jin, Kosen, Soewarta, Krohn, Kris J., Kusuma, Dian, La Vecchia, Carlo, Lansingh, Van Charles, Lee, Paul H., LeGrand, Kate E., Li, Shanshan, Longbottom, Joshua, Magdy Abd El Razek, Hassan, Magdy Abd El Razek, Muhammed, Maleki, Afshin, Mamun, Abdullah A., Manafi, Ali, Manafi, Navid, Mansournia, Mohammad Ali, Martins-Melo, Francisco Rogerlândio, Mazidi, Mohsen, McAlinden, Colm, Meharie, Birhanu Geta, Mendoza, Walter, Mengesha, Endalkachew Worku, Mengistu, Desalegn Tadese, Mereta, Seid Tiku, Mestrovic, Tomislav, Miller, Ted R., Miri, Mohammad, Moghadaszadeh, Masoud, Mohammadian-Hafshejani, Abdollah, Mohammadpourhodki, Reza, Mohammed, Shafiu, Mohammed, Salahuddin, Moradi, Masoud, Moradzadeh, Rahmatollah, Moraga, Paula, Mosser, Jonathan F., Naderi, Mehdi, Nagarajan, Ahamarshan Jayaraman, Naik, Gurudatta, Negoi, Ionut, Nguyen, Cuong Tat, Nguyen, Huong Lan Thi, Nguyen, Trang Huyen, Nikbakhsh, Rajan, Oancea, Bogdan, Olagunju, Tinuke O., Olagunju, Andrew T., Omar Bali, Ahmed, Onwujekwe, Obinna E., Pana, Adrian, Pourjafar, Hadi, Rahim, Fakher, Rahman, Mohammad Hifz Ur, Rathi, Priya, Rawaf, Salman, Rawaf, David Laith, Rawassizadeh, Reza, Resnikoff, Serge, Reta, Melese Abate, Rezapour, Aziz, Rubagotti, Enrico, Rubino, Salvatore, Sadeghi, Ehsan, Saghafipour, Abedin, Sajadi, S. Mohammad, Samy, Abdallah M., Sarmiento-Suárez, Rodrigo, Sawhney, Monika, Schipp, Megan F., Shaheen, Amira A., Shaikh, Masood Ali, Shamsizadeh, Morteza, Sharafi, Kiomars, Sheikh, Aziz, Shetty, B. Suresh Kumar, Shin, Jae Il, Shivakumar, K. M., Simonetti, Biagio, Singh, Jasvinder A., Skiadaresi, Eirini, Soheili, Amin, Soltani, Shahin, Spurlock, Emma Elizabeth, Sufiyan, Mu’awiyyah Babale, Tabuchi, Takahiro, Tapak, Leili, Thompson, Robert L., Thomson, Alan J., Traini, Eugenio, Tran, Bach Xuan, Ullah, Irfan, Ullah, Saif, Uneke, Chigozie Jesse, Unnikrishnan, Bhaskaran, Uthman, Olalekan A., Vinkeles Melchers, Natalie V. S., Violante, Francesco S., Wolde, Haileab Fekadu, Wonde, Tewodros Eshete, Yamada, Tomohide, Yaya, Sanni, Yazdi-Feyzabadi, Vahid, Yip, Paul, Yonemoto, Naohiro, Yousof, Hebat-Allah Salah A., Yu, Chuanhua, Yu, Yong, Yusefzadeh, Hasan, Zaki, Leila, Zaman, Sojib Bin, Zamanian, Maryam, Zhang, Zhi-Jiang, Zhang, Yunquan, Ziapour, Arash, Hay, Simon I., Pigott, David M.
    Publicado 2021
    “…Mean estimates of environmental suitability suggest large areas across West and Central Africa, as well as focal areas of East Africa, are suitable for onchocerciasis transmission, consistent with the presence of current control and elimination of transmission efforts. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS